BOAI NKY MEDICAL HOLDINGS LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.19 CNY | +1.51% |
|
-0.27% | +23.00% |
| Apr. 26 | Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2023 | CI |
| Apr. 25 | Boai NKY Medical Holdings Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Boai NKY Medical Holdings Ltd., formerly Boai NKY Pharmaceuticals Ltd., is a China-based company principally engaged in the research, development, production and distribution of polyvinyl pyrrolidone (PVP) series products and polyvinyl methyl ether and maleic anhydride (PVME/MA) series products. The Companyâs main products include GBL, 2- pyrrolidone, N-vinylpyrrolidone (NVP) monomer, PVP-K series (PVPK), polyvinylpolypyrrolidone (PPVP), PVP- Iodine (PVP-I), related pharmaceutical intermediates and others. The Company's products are mainly used in daily chemical, medicine, liquor and beverage, pigments and coatings, textile, paper making, oil extraction, sensitive material, electronic and other industries. The Company distributes its products in domestic market and to overseas markets.
Sector
Specialty Chemicals
Calendar
2024-05-23
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.00% | 944M | |
| +16.91% | 66.22B | |
| +1.64% | 49.24B | |
| +16.70% | 41.4B | |
| +21.48% | 26.62B | |
| +12.92% | 19.84B | |
| +2.79% | 17.44B | |
| -23.54% | 15.57B | |
| -6.24% | 15.92B | |
| +2.52% | 15.45B |
- Stock Market
- Equities
- 300109 Stock
- News Boai NKY Medical Holdings Ltd.
- Boai NKY Medical Repurchases 14 Million Shares